RICTOR deficiency alters post-translational modifications in NAMPT likely affecting its activation and/or stability, which is suggestive of a complex interplay between mTORC2 signaling and NAD+ biosynthesis in melanoma. The gene discussed is NAMPT; the disease is melanoma.